A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial (Englisch)
- Neue Suche nach: Bui-Nguyen, B.
- Neue Suche nach: Butrynski, J.E.
- Neue Suche nach: Penel, N.
- Neue Suche nach: Blay, J.Y.
- Neue Suche nach: Isambert, N.
- Neue Suche nach: Milhem, M.
- Neue Suche nach: Kerst, J.M.
- Neue Suche nach: Reyners, A.
- Neue Suche nach: Bui-Nguyen, B.
- Neue Suche nach: Butrynski, J.E.
- Neue Suche nach: Penel, N.
- Neue Suche nach: Blay, J.Y.
- Neue Suche nach: Isambert, N.
- Neue Suche nach: Milhem, M.
- Neue Suche nach: Kerst, J.M.
- Neue Suche nach: Reyners, A.
In:
EUROPEAN JOURNAL OF CANCER -A-
;
51
, 10
;
1312-1320
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial
-
Beteiligte:Bui-Nguyen, B. ( Autor:in ) / Butrynski, J.E. ( Autor:in ) / Penel, N. ( Autor:in ) / Blay, J.Y. ( Autor:in ) / Isambert, N. ( Autor:in ) / Milhem, M. ( Autor:in ) / Kerst, J.M. ( Autor:in ) / Reyners, A. ( Autor:in )
-
Erschienen in:EUROPEAN JOURNAL OF CANCER -A- ; 51, 10 ; 1312-1320
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:9 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 51, Ausgabe 10
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1203
-
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term carePanCare Network / Hjorth, L. / Haupt, R. / Skinner, R. / Grabow, D. / Byrne, J. / Karner, S. / Levitt, G. / Michel, G. et al. | 2015
- 1212
-
Fulvestrant with or without selumetinib, a MEK 12 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 2108Zaman, K. / Winterhalder, R. / Mamot, C. / Hasler-Strub, U. / Rochlitz, C. / Mueller, A. / Berset, C. / Wiliders, H. / Perey, L. et al. | 2015
- 1221
-
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysiseusomaDB Working Group / Kiderlen, M. / Ponti, A. / Tomatis, M. / Boelens, P.G. / Bastiaannet, E. / Wilson, R. / van de Velde, C.J.H. / Audisio, R.A. et al. | 2015
- 1231
-
Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancerDouillard, J.Y. / Siena, S. / Peeters, M. / Koukakis, R. / Terwey, J.H. / Tabernero, J. et al. | 2015
- 1243
-
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerBokemeyer, C. / Kohne, C.H. / Ciardiello, F. / Lenz, H.J. / Heinemann, V. / Klinkhardt, U. / Beier, F. / Duecker, K. / van Krieken, J.H. et al. | 2015
- 1253
-
Streptozocin5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumoursDilz, L.M. / Denecke, T. / Steffen, I.G. / Prasad, V. / von Weikersthal, L.F. / Pape, U.F. / Wiedenmann, B. / Pavel, M. et al. | 2015
- 1263
-
Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: Results from the population-based PROFILES registryVerhaar, S. / Vissers, P.A.J. / Maas, H. / van de Poll-Franse, L.V. / van Erning, F.N. / Mols, F. et al. | 2015
- 1274
-
Combination antiemetic therapy with aprepitantfosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trialMulti-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO) / Nishimura, J. / Satoh, T. / Fukunaga, M. / Takemoto, H. / Nakata, K. / Ide, Y. / Fukuzaki, T. / Kudo, T. et al. | 2015
- 1283
-
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 studyon behalf of the Scandinavian Prostate Cancer Group / Thomsen, F.B. / Brasso, K. / Christensen, I.J. / Johansson, J.E. / Angelsen, A. / Tammela, T.L.J. / Iversen, P. et al. | 2015
- 1293
-
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patientsPowles, T. / Bracarda, S. / Chen, M. / Norry, E. / Compton, N. / Heise, M. / Hutson, T. / Harter, P. / Carpenter, C. et al. | 2015
- 1303
-
Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patientsCho, J.K. / Lee, G.J. / Yi, K.I. / Cho, K.S. / Choi, N. / Kim, J.S. / Kim, H. / Oh, D. / Choi, S.K. et al. | 2015
- 1312
-
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trialBui-Nguyen, B. / Butrynski, J.E. / Penel, N. / Blay, J.Y. / Isambert, N. / Milhem, M. / Kerst, J.M. / Reyners, A. et al. | 2015
- 1321
-
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trialDirven, L. / van den Bent, M.J. / Bottomley, A. / van der Meer, N. / van der Holt, B. / Vos, M.J. / Walenkamp, A.M.E. / Beerepoot, L.V. et al. | 2015
- 1331
-
Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative CareLindskog, M. / Tavelin, B. / Lundstrom, S. et al. | 2015
- 1340
-
Childhood height increases the risk of prostate cancer mortalityAarestrup, J. / Gamborg, M. / Cook, M.B. / Baker, J.L. et al. | 2015
- 1346
-
Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopiesBrenner, H. / Altenhofen, L. / Stock, C. / Hoffmeister, M. et al. | 2015